Loading...
Symbols:
Loading...
Symbols:
Human Genome Sciences Inc. (HGSI)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Human Genome Sciences Inc. (HGSI)
13 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on HGSI
- Centient Biotech Investor(3)
- Ketan Desai (2)
- SA Editor Miriam Metzinger(2)
- Dan Rosenblum (1)
- Michael Shaffer(1)
Most popular authors
(tracked in watchlists)
- SA Editor Miriam Metzinger(116)
- Eddy Elfenbein(44)
- Ketan Desai (13)
- Fredric Cohen, M.D.(4)
- Centient Biotech Investor(3)
Most commented on authors
- Ketan Desai (3)
- Dan Rosenblum (1)
- Eddy Elfenbein(0)
- Michael Shaffer(0)
- Centient Biotech Investor(0)
- Human Genome Sciences Awaiting Crucial Albuferon Data
- Bioterrorism: Anthrax and Biotech Companies
- Biotech Stocks' Various Lupus Therapies: Opportunity or Lost Cause?
- Insider Buying in Biotech Land
- Hepatitis C Developments Drag Biotechs Down
- PowerHouse Week for Economic Calendar
- Biotech Day in Review: Xoma Signs $230 Million Partnership with Takeda
- Glaxo and HGS's Announcement: Reading Between the Lines
- Biotech Day In Review: Another Setback for Acomplia from Sanofi-Aventis
- Biotech Stocks Day-in-Review: Amgen Strikes Drug Deal With Cytokinetics
- IPO Analysis: Perlegen and Genetically Targeted Medications (PERL)
- How Does Human Genome Sciences Survive with Zero Products In the Market? (HGSI)
-
Stocks Covered by The Biotech Stock Blog
on Oct 11, 2005
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »